The number of T cells tended to be decreased in patients treated with infliximab (-52 ± 32) but not in the placebo group (+10 ± 25); this difference did not reach statistical significance.
← all excerpts
Infliximab treatment reduces synovial cellularity as early as 48 hours after initiation of treatment, but not by induction of apoptosis
1
—
—